Your browser doesn't support javascript.
loading
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.
Pepys, M B; Herbert, J; Hutchinson, W L; Tennent, G A; Lachmann, H J; Gallimore, J R; Lovat, L B; Bartfai, T; Alanine, A; Hertel, C; Hoffmann, T; Jakob-Roetne, R; Norcross, R D; Kemp, J A; Yamamura, K; Suzuki, M; Taylor, G W; Murray, S; Thompson, D; Purvis, A; Kolstoe, S; Wood, S P; Hawkins, P N.
Affiliation
  • Pepys MB; Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, London NW3 2PF, UK. m.pepys@rfc.ucl.ac.uk
Nature ; 417(6886): 254-9, 2002 May 16.
Article in En | MEDLINE | ID: mdl-12015594
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Serum Amyloid P-Component / Amyloidosis Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Nature Year: 2002 Document type: Article Affiliation country: United kingdom
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Serum Amyloid P-Component / Amyloidosis Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Nature Year: 2002 Document type: Article Affiliation country: United kingdom